Last Chance to Save on What’s Hot in Seattle Biotech

Xconomy National — 

There’s just one week left before Xconomy’s latest biotech event, “What’s Hot in Seattle Biotech.” Don’t let the clock run out while you can still save some cash on a ticket.

Next Tuesday, June 12, we’re bringing together some of the Emerald City’s top life science entrepreneurs, scientists, and investors to discuss the strengths and challenges of Seattle’s life science community. Don’t wait to register—our Procrastinator’s Special ends soon and it’s your last chance at a discount.

Speakers include:

  • Leen Kawas, CEO, M3 Biotechnology
  • Harlan Robins, Co-founder & Head of Innovation, Adaptive Biotechnologies
  • Desney Tan, General Manager, Microsoft Healthcare NExT
  • Claudia Mitchell, CEO, Universal Cells
  • Peter Thompson, Chairman, Silverback Therapeutics
  • Ivan Liachko, CEO, Phase Genomics
  • Lara Mangravite, President, Sage Bionetworks
  • Nicholas Mark, Medical Director, KenSci
  • VK Gadi, Medical Director & Co-Founder, SEngine Precision Medicine
  • Maura Little, Executive Director, Cambia Grove
  • Jon Congleton, CEO, Impel NeuroPharma
  • Amy Bernard, Product Architect, Allen Institute for Brain Science
  • Dan Wattendorf, Director of Innovative Technology Solutions, Bill & Melinda Gates Foundation
  • Heather Franklin, President & CEO, Blaze Bioscience
  • Bill Watt, Co-Founder & CEO, EpiThany

You can find the full agenda for the day here.

This is an event you won’t want to miss, so grab your ticket today. See you there!